谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Updated Efficacy and Subgroup Analysis of First-Line Serplulimab Plus Bevacizumab and XELOX Versus Placebo Plus Bevacizumab and XELOX in Metastatic Colorectal Cancer: A Phase 2/3 Study.

Rui-Hua Xu,Feng Wang, Zi-Xian Wang,Junjie Peng,Xinjun Liang,Ying Cheng,Yanhong Deng,Kehe Chen, Mingjun Zhang,Jingdong Zhang, Wei Wang,Bangwei Cao, Yongdong Jin, Meili Sun, Yuan Lin,Suxia Luo, Zhen Li,Liu Yang, Qingyu Wang, Jun Zhu

Journal of Clinical Oncology（2025）

引用 0|浏览9
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要